ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 457

Neuropathic Pain in Patients with Knee Osteoarthritis (Preliminary Report)

Pinar Borman1, Ferda Kaygisiz2 and Aysegul Yaman3, 1Department of Physical Medicine and Rehabilitation, University of Hacettepe Faculty of Medicine, Ankara, Turkey, 2Dept of PMR, Ankara Training and Research Hospital, Ankara, Turkey, 3Dept of PMR, University of Hacettepe Faculty of Medicine, Ankara, Turkey

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Knee, neuropathy, osteoarthritis and pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Pain Mechanisms – Basic and Clinical Science Poster – ARHP

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: There are limited studies in the literature indicating that neuropathic pain occurs in knee osteoarthritis (OA) (1). The aim of this cross sectional study was to evaluate frequency of neuropathic pain in knee OA patients and to determine the relation with disease variables.

Methods: Twenty knee OA patients who were not having any comorbid disease and/or using drugs that would cause neuropathy, were recruited to the study. Demographic properties (age, sex, disease duration) and clinical characteristics (functional status by WOMAC and pain intensity by VAS) recorded. The neuropathic property of knee pain was assessed by both LANSS and DN4 scales. Descriptive statistics was used for clinical variables and frequency of neuropathic pain. The difference of clinical variables between patients with and without neuropathic pain, were examined using t tests and chi square tests for continuous and categorical variables respectively. Correlation coefficients of clinical variables and neuropathic pain scores determined by LANSS and DN4, were analyzed with Spearman correlation analyses. The significance threshold was set as p values less than 0.05.

Results: Twenty knee OA patients (11 female, 9male) with a mean age of 55±18 years were included to the study. 11 patients (55%) were defined as having neuropathic pain depending on the LANSS (scores≥12) and DN4 (scores≥4) questionnaire scores. The mean scores of LANSS scale and DN4 were correlated with WOMAC scores

Conclusion: In conclusion neuropathic pain may be common in knee OA patients. Diagnosis and treatment of neuropathic pain are warranted in order to increase functional disability in patients suffering from knee OA.

References

  1. Dimitroulas T, Duarte RV, Behura A3, Kitas GD, Raphael Neuropathic pain in osteoarthritis: a review of pathophysiological mechanisms and implications for treatment. Semin Arthritis Rheum. 2014 Oct;44(2):145-54.

Disclosure: P. Borman, None; F. Kaygisiz, None; A. Yaman, None.

To cite this abstract in AMA style:

Borman P, Kaygisiz F, Yaman A. Neuropathic Pain in Patients with Knee Osteoarthritis (Preliminary Report) [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/neuropathic-pain-in-patients-with-knee-osteoarthritis-preliminary-report/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neuropathic-pain-in-patients-with-knee-osteoarthritis-preliminary-report/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology